Koya Medical ("Koya"), a medical technology company advancing evidence-based therapies for venous and lymphatic disease, ...
Of the 58 participants enrolled, 47 completed the initial comparison between a one-month ketogenic diet intervention and a diet-as-usual control group. Twenty-five participants opted to continue the ...
A study by researchers at U.S. health insurance and medical services provider Kaiser Permanente, the Food is Medicine ...
Among patients with atrial fibrillation and predominantly chronic coronary syndrome undergoing PCI with intravascular imaging ...
Tesamorelin can selectively reduce visceral fat, as demonstrated in RCTs. But the real story is what it reveals about ...
DEEp OCEAN is a global trial designed to evaluate the investigational molecule bexicaserin for the treatment of seizures ...
Mean LDL-C at 6 months was 76.3 vs 85.6 mg/dL, yielding an adjusted difference of −6.62 mg/dL and higher attainment of LDL-C <50 mg/dL. Intervention uptake increased intensive and combination ...
Actinogen Medical Limited (ASX: ACW) today announces that results from its proof-of-concept trial, entitled “A phase 2 ...
Suzhou Ribo Life Science and subsidiary Ribocure Pharmaceuticals, collectively known as Ribo, has reported initial results from its Phase IIa clinical trial of vortosiran (RBD4059 ...
Morning Overview on MSN
A cannabis compound calmed agitation in advanced dementia in a new trial
Families caring for loved ones with advanced dementia and severe agitation now have a new piece of clinical evidence to weigh ...
Researchers conducted a cross-sectional analysis of recent myeloma randomized clinical trials to evaluate the prevalence and characteristics of reporting spin in study findings.
A study from researchers at top US health insurance and medical services provider Kaiser Permanente, the Food is Medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results